Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ECO Animal Health is a global leader in animal health pharmaceuticals with a focus on respiratory and enteric disease solutions for swine and poultry. Its flagship product Aivlosin® is one of the top 30 brands worldwide for livestock. The company also markets antiparasitic drugs such as Ecomectin. It continues to invest heavily in R&D for vaccines and alternative therapies to reduce antibiotic use. New pipeline details are limited but include ongoing research into biologics such as antibody-based therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ECO Animal Health.